Institutional Biosafety Committee (IBC)

All research that involves rDNA molecules must be in compliance with the NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines). The NIH Guidelines set forth principles and standards for safe and ethical conduct of recombinant DNA research and apply to both basic and clinical research studies.

The Institutional Biosafety Committee (IBC) is responsible for approving risk assessment and the biosafety containment levels for such experiments.

• Registration for Biosafety Level 1, 2, and 3 Protocols
  
• Determining Safety Levels
  
• Human Gene Transfer Program

Policies:

• NYUSM Policies for Working with rDNA
  
• NIH rDNA Policy
  
• NIH Stem Cell Policy
  
• NYUSM Institutional Biosafety Committee Membership Roster